Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure

Sujittra Chaisavaneeyakorn, Nopporn Apiwattanakul, Chonnamet Techasaensiri, Nattakarn Tantawarak, Bandit Thinkhamrop, Supattra Rungmaitree, Siriporn Phongjitsiri, Tavitiya Sudjaritruk, Suvaporn Anugulruengkitt, Pope Kosalaraksa, Thirapa Nivesvivat, Puttichart Khantee, Pornumpa Bunjoungmanee, Panit Takkinsatian, Thiraporn Kanjanaphan, Rudiwilai Samakoses, Tim R. Cressey, Henry Pertinez, Andrew Owen, Kulkanya Chokephaibulkit

Open source

DOI
10.2478/abm-2026-0011
Published
2026-04-01
Container
Asian Biomedicine
Publisher
Walter de Gruyter GmbH
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2478/abm-2026-0011,
  title = {Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure},
  author = {Sujittra Chaisavaneeyakorn and Nopporn Apiwattanakul and Chonnamet Techasaensiri and Nattakarn Tantawarak and Bandit Thinkhamrop and Supattra Rungmaitree and Siriporn Phongjitsiri and Tavitiya Sudjaritruk and Suvaporn Anugulruengkitt and Pope Kosalaraksa and Thirapa Nivesvivat and Puttichart Khantee and Pornumpa Bunjoungmanee and Panit Takkinsatian and Thiraporn Kanjanaphan and Rudiwilai Samakoses and Tim R. Cressey and Henry Pertinez and Andrew Owen and Kulkanya Chokephaibulkit},
  year = {2026},
  journal = {Asian Biomedicine},
  doi = {10.2478/abm-2026-0011},
  url = {https://doi.org/10.2478/abm-2026-0011}
}

RIS

TY  - JOUR
TI  - Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure
AU  - Sujittra Chaisavaneeyakorn
AU  - Nopporn Apiwattanakul
AU  - Chonnamet Techasaensiri
AU  - Nattakarn Tantawarak
AU  - Bandit Thinkhamrop
AU  - Supattra Rungmaitree
AU  - Siriporn Phongjitsiri
AU  - Tavitiya Sudjaritruk
AU  - Suvaporn Anugulruengkitt
AU  - Pope Kosalaraksa
AU  - Thirapa Nivesvivat
AU  - Puttichart Khantee
AU  - Pornumpa Bunjoungmanee
AU  - Panit Takkinsatian
AU  - Thiraporn Kanjanaphan
AU  - Rudiwilai Samakoses
AU  - Tim R. Cressey
AU  - Henry Pertinez
AU  - Andrew Owen
AU  - Kulkanya Chokephaibulkit
PY  - 2026
JO  - Asian Biomedicine
DO  - 10.2478/abm-2026-0011
UR  - https://doi.org/10.2478/abm-2026-0011
ER  - 

APA

Chaisavaneeyakorn, S., Apiwattanakul, N., Techasaensiri, C., Tantawarak, N., Thinkhamrop, B., Rungmaitree, S., Phongjitsiri, S., Sudjaritruk, T., Anugulruengkitt, S., Kosalaraksa, P., Nivesvivat, T., Khantee, P., Bunjoungmanee, P., Takkinsatian, P., Kanjanaphan, T., Samakoses, R., Cressey, T. R., Pertinez, H., Owen, A., & Chokephaibulkit, K. (2026). Favipiravir treatment in Thai children with COVID-19: effectiveness, safety, and modeling drug exposure. Asian Biomedicine. https://doi.org/10.2478/abm-2026-0011

Source records